+
Site Tour

Search

Showing 121 - 130 of 532 results.

  • Guidelines & Recommendations

    SWITCH TO THE interventional VIEW    For more information specific to interventional cardiology regarding LAA Occlusion 2024 EUROPEAN SOCIETY OF CARDIOLOGY (ESC) GUIDELINES FOR THE MANAGE

  • Patients who benefit

    SWITCH TO THE interventional VIEW    For more information specific to interventional cardiology regarding LAA Occlusion

  • Overview

    SWITCH TO THE interventional VIEW    For more information specific to interventional cardiology regarding LAA Occlusion AF AND THE CHALLENGES OF MEDICATION Many patients at risk of str

  • Clinical Data

    SVD: structural valve deterioration. *From stand-alone aortic or mitral valve replacements.   THE EPIC PLATFORM HAS DEMONSTRATED EXCELLENT DURABILITY IN YOUNGER PATIENTS The Epic Mitral va

  • Classification

    aThis algorithm can be applied to all patients with advanced HF defined according to the HFA-ESC criteria,5 with exception of hypertrophic cardiomyopathy (HCM), cardiac arrest (CA), arrhythmic storm

  • Diagnosis

    Figure 1: The diagnostic algorithm for heart failure. BNP=B-type natriuretic peptide; ECG=electrocardiogram; HFmrEF=heart failure with mildly reduced ejection fraction; HFpEF=heart failure with pres

  • Guidelines & Recommendations

    Compelling data resulted in positive guidelines recommending PFO closure Long-term data from the both the RESPECT trial12 and REDUCE trial,13 as well as data from the CLOSE trial,14 have revealed tha

  • Transcatheter Mitral Valve implant - 2025

    Transcatheter Mitral Valve implant : procedural and post-procedural echo guiding

  • TAVI webinar - key learnings in TAVI

    TAVI in low and intermediate risk patients: what do we know

  • bRIGHT clinical data release | PCR LV 2025

    bRIGHT procedural clipping strategy presented at PCR LV 2025 by X. Freixa

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline